Meg Rivers

Amy West, Head of US Digital Health & Innovation Strategy at Novo Nordisk, shares her insights on fostering collaboration, embracing change, and her compelling vision to revolutionize digital transformation and innovation in the field of healthcare.

It’s with a heavy heart that I share my departure from Pharmaceutical Executive.® It’s hard to believe that one year ago (in September 2022) I began my journey with the team here and the publication (and with all of you!). First and foremost, a huge thank you to you, the reader, for trusting me to share content with you.

In this Q&A with Pharmaceutical Executive®, Andrew Hopkins, founder and CEO of Exscientia, reveals how artificial intelligence (AI) is currently being utilized in the pharma industry, predictions for where AI can be implemented in the future, and what pharma fears most about AI.

An expert from Flagship Pioneering, the venture creation firm behind Moderna and other life science firms, shares the process of founding a company, how they decide whether to partner with companies, the importance of collaboration and how they approach it, and where science is booming in pharma right now.

George Hampton, president and CEO, Currax Pharmaceuticals, discusses the obesity treatment landscape, payment options available to insured and uninsured patients, and how pharma can make obesity treatments more affordable in an exclusive Q&A with Pharm Exec.

Lung-I Cheng, vice president of cell and gene therapy (CGT), Cencora (formerly AmerisourceBergen), discusses CGT commercialization strategies, common knowledge gaps, and what he wishes companies knew about commercialization strategies.